We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
DAXX
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

ANTIBODY INFORMATION VALIDATION SUMMARY IMMUNOCYTOCHEMISTRY IMMUNOHISTOCHEMISTRY WESTERN BLOT PROTEIN ARRAY ANTIGEN INFORMATION RELEVANT PUBLICATIONS

ANTIBODY INFORMATION

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

Provider

Atlas Antibodies
Sigma-Aldrich
  Atlas Antibodies
Sigma-Aldrich
  Atlas Antibodies
Sigma-Aldrich
  Novocastra
  R&D Systems
 

Product name

HPA008736   HPA008797   HPA065779   NCL-DAXX   AF4548  

Host species

Rabbit   Rabbit   Rabbit   Mouse   Goat  

Clonality

pAb   pAb   pAb   mAb   msAb  

Purity

Affinity purified using the PrEST-antigen as affinity ligand   Affinity purified using the PrEST-antigen as affinity ligand   Affinity purified using the PrEST-antigen as affinity ligand   Not known   Affinity  

Other gene match

         

Released in version

3   3   14   1   5  

References

9          

Proper citation

Atlas Antibodies Cat#HPA008736, RRID:AB_1078625     Atlas Antibodies Cat#HPA065779, RRID:AB_2685558      

VALIDATION SUMMARY

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 
Immunocytochemistry

 

Validated

Validated
 

Validated

Validated
     
Immunohistochemistry

Supported       Supported   Supported  
Western blot

Supported   Supported   Supported   Uncertain   Uncertain  
Protein array

Supported   Supported   Supported      

IMMUNOCYTOCHEMISTRY

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

Formal validation: Tagged protein

 
Validated

Antibody staining overlaps with GFP tagged protein
 
Validated

Antibody staining overlaps with GFP tagged protein
     

         

Figure description

  Immunofluorescent staining of transgenic HeLa cells show antibody staining in nucleus & nuclear bodies and GFP expression in nucleus & nuclear bodies.   Immunofluorescent staining of transgenic HeLa cells show antibody staining in nucleus & nuclear bodies and GFP expression in nucleus & nuclear bodies.      

Antibody dilution

  1:24   1:125      
 

Formal validation: Independent

 
Validated

Antibody staining overlaps with antibody HPA065779.
 
Validated

Antibody staining overlaps with antibody HPA008797.
     
 

Standard validation

  Supported   Supported      

         

Figure description

  Immunofluorescent staining of human cell line A-431 shows localization to nucleus & nuclear bodies.   Immunofluorescent staining of human cell line SH-SY5Y shows localization to nucleus & nuclear bodies.      

Antibody dilution

  1:20   1:125      

Literature conformity

  The subcellular location is supported by literature.   The subcellular location is supported by literature.      

IMMUNOHISTOCHEMISTRY

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

Standard validation

Supported       Supported   Supported  

         

Figure description

Immunohistochemical staining of human tonsil shows strong nuclear positivity in germinal center and non-germinal center cells.       Immunohistochemical staining of human lymph node shows strong cytoplasmic and nuclear positivity in reaction center cells and lymphoid cells outside reaction centra.   Immunohistochemical staining of human tonsil shows moderate nuclear positivity in reaction center cells.  

Expression

RNA: detected in 35 tissues
Protein: detected in 75 cell types
      RNA: detected in 35 tissues
Protein: detected in 63 cell types
  RNA: detected in 35 tissues
Protein: detected in 64 cell types
 

Retrieval

HIER pH6       HIER pH6   HIER pH6  

Antibody dilution

1:75       1:100   1:75  

Literature conformity

Consistent with extensive gene/protein characterization data.       Consistent with extensive gene/protein characterization data.   Consistent with extensive gene/protein characterization data.  

RNA consistency

Mainly consistent with RNA expression data.       Mainly consistent with RNA expression data.   Mainly consistent with RNA expression data.  

WESTERN BLOT

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

Standard validation

Supported

Single band corresponding to the predicted size in kDa (+/-20%).
  Supported

Analysis performed using a standard panel of samples.
Single band corresponding to the predicted size in kDa (+/-20%).
  Supported

Analysis performed using a standard panel of samples.
Band of predicted size in kDa (+/-20%) with additional bands present.
  Uncertain

Analysis performed using a standard panel of samples.
Weak band of predicted size but with additional bands of higher intensity also present.
  Uncertain

Analysis performed using a standard panel of samples.
Weak band of predicted size but with additional bands of higher intensity also present.
 

         

Figure description

Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10
Lane 2: Negative control (vector only transfected HEK293T lysate)
Lane 3: Over-expression Lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY427987)
  Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
  Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10
Lane 2: RT4
Lane 3: U-251 MG
Lane 4: Human Plasma
Lane 5: Liver
Lane 6: Tonsil
     

Target mass (kDa)

81.4, 76.3, 73.6   81.4, 76.3, 73.6   81.4, 76.3, 19.1   81.4, 76.3, 73.6, 19.1, 14.2, 4.8   81.4, 76.3, 73.6, 19.1, 14.2, 4.8  

Antibody dilution

1:125   1:250   1:420   1:500   1:500  

PROTEIN ARRAY

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

Standard validation

Supported

Pass with single peak corresponding to interaction only with its own antigen.
  Supported

Pass with single peak corresponding to interaction only with its own antigen.
  Supported

Pass with single peak corresponding to interaction only with its own antigen.
     

         

Figure description

Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.   Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.   Antibody specificity analysis with protein arrays. Predicted and matching interactions are shown in green.      

Antibody dilution

1:500   1:500   1:5000      

ANTIGEN INFORMATION

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

Antigen

Recombinant protein fragment   Recombinant protein fragment   Recombinant protein fragment   Not known   Recombinant protein  

Length (aa)

146   146   136      

Antigen sequence

DEEEEAAAGKDGDKSPMSSLQISNEKNLEPGKQISRSSGEQQNKGRIVSP
SLLSEEPLAPSSIDAESNGEQPEELTLEEESPVSQLFELEIEALPLDTPS
SVETDISSSRKQSEEPFTTVLENGAGMVSSTSFNGGVSPHNWGDSG
 
DEEEEAAAGKDGDKSPMSSLQISNEKNLEPGKQISRSSGEQQNKGRIVSP
SLLSEEPLAPSSIDAESNGEQPEELTLEEESPVSQLFELEIEALPLDTPS
SVETDISSSRKQSEEPFTTVLENGAGMVSSTSFNGGVSPHNWGDSG
 
ARGSSSSGGKKCYKLENEKLFEEFLELCKMQTADHPEVVPFLYNRQQRAH
SLFLASAEFCNILSRVLSRARSRPAKLYVYINELCTVLKAHSAKKKLNLA
PAATTSNEPSGNNPPTHLSLDPTNAENTASQSPRTR
 
 
 

Matching transcripts

DAXX-001 - ENSP00000363668 [100%]
DAXX-002 - ENSP00000266000 [100%]
DAXX-201 - ENSP00000396876 [100%]
DAXX-202 - ENSP00000482399 [100%]
  DAXX-001 - ENSP00000363668 [100%]
DAXX-002 - ENSP00000266000 [100%]
DAXX-201 - ENSP00000396876 [100%]
DAXX-202 - ENSP00000482399 [100%]
  DAXX-001 - ENSP00000363668 [100%]
DAXX-002 - ENSP00000266000 [100%]
DAXX-202 - ENSP00000482399 [100%]
DAXX-007 - ENSP00000406008 [97%]
     

Other gene match

         
ANTIGEN VIEW
DAXX-001
DAXX-002
DAXX-007
DAXX-201
DAXX-202

RELEVANT PUBLICATIONS

 
 

Antibody HPA008736

 

Antibody HPA008797

 

Antibody HPA065779

 

Antibody CAB002224

 

Antibody CAB025546

 

1.

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber J et al
Nature 2012;482(7384):226-31
         

2.

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
de Wilde RF et al
Mod Pathol 2012;25(7):1033-9
         

3.

Altered telomeres in tumors with ATRX and DAXX mutations
Heaphy CM et al
Science 2011;333(6041):425
         

4.

Sp100 provides intrinsic immunity against human papillomavirus infection
Stepp WH et al
MBio 2013;4(6):e00845-13
         

5.

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Fishbein L et al
Nat Commun 2015;6:6140
Application: IHC
         

6.

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
Pipinikas CP et al
Endocr Relat Cancer 2015;22(3):L13-8
Application: IHC
         

7.

ATRX represses alternative lengthening of telomeres
Napier CE et al
Oncotarget 2015;6(18):16543-58
Application: WB
         

8.

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast
Yoshida M et al
Br J Cancer 2015;113(8):1244-8
Application: IHC
         

9.

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
Mäkinen N et al
PLoS Genet 2016;12(2):e1005850
Application: IHC
         
 

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.